|
Childhood Obesity Surveillance Initiative - Belgium |
COSI |
June 1, 2020 |
|
Health information |
overweight, obesity, monitoring, children |
|
Characterisation and risk evaluation of counterfeit antibiotics on the European market |
counterfeit antibiotics |
October 1, 2016 |
October 1, 2020 |
Medicines and health products |
counterfeit antibiotics, quality control, impurities, market study |
|
COVID-19-barometer in general practices - version 2.0 |
COVID-19 BM 2.0 |
October 1, 2020 |
December 31, 2025 |
Health services research |
COVID-19, surveillance, médecine générale, soins de santé primaire |
|
Epidemiological surveillance of COVID-19 mortality |
COVID-19 Mortality |
March 1, 2020 |
June 30, 2023 |
Epidemiology of infectious diseases |
COVID-19, mortality, COVID-19 mortality, deaths, surveillance, pandemic, monitoring, infectious diseases |
|
COVID-19 Health surveys |
COVID19HIS |
March 1, 2020 |
July 1, 2024 |
|
survey, COVID-19, mental health, social health, vaccination, lifestyle |
|
Development of a method to assess the diversity of SARS-CoV-2 circulating strains in Belgium |
COVIDDIVER |
January 1, 2021 |
January 1, 2022 |
Viral diseases, Cancer centre , Transversal activities in applied genomics |
ddPCR, epidemic, COVID-19, SARS-CoV-2, wastewater, clinical samples |
|
Long COVID and its physical, mental and social implications |
COVIMPACT |
April 29, 2021 |
April 29, 2023 |
Health information, Epidemiology of infectious diseases |
COVID-19, long COVID, physical health, mental health, social health |
|
Monitoring the performance of detection methods for SARS-CoV-2 in clinical samples using sequencing data |
COVIPRIM |
April 1, 2020 |
December 31, 2020 |
Viral diseases, Quality of laboratories , Transversal activities in applied genomics |
|
|
Monitoring of the whole genome sequencing (WGS) data of SARS-CoV-2 genomes to identify variants and their impact on detection methods |
COVIPRIM_VAR2 |
February 1, 2021 |
December 31, 2021 |
Quality of laboratories , Transversal activities in applied genomics |
NGS, computational biology, bioinformatics, mutations, variants, database, disease outbreaks, performance evaluation, SARS-CoV-2, COVID-19, qPCR, disease transmission |
|
National surveillance of SARS-CoV-2 and its variants in wastewater. |
CoVWWSurv |
September 14, 2020 |
|
Foodborne pathogens, Epidemiology of infectious diseases, Transversal activities in applied genomics |
COVID-19, SARS-CoV-2, epidemiology, surveillance, environment, variants, applied genomics, wastewater |
|
Joint Action on network of Comprehensive Cancer Centres |
CraNE |
November 1, 2022 |
October 31, 2024 |
Cancer centre |
cancer, comprehensive cancer centres, cancer care organisation and networks, expertise |
|
Central Registry Rare Diseases |
CRRD |
January 1, 2012 |
|
Health services research |
patient registry, rare diseases, epidemiology, genetic centre, ORPHA-code, Healthdata.be, clinical trial recruitment, common data set |
|
The presence of Chlamydia trachomatis among the population in Belgium |
CTstudy |
May 1, 2019 |
May 1, 2020 |
Epidemiologie van infectieziekten |
|
|
Support of Theileria vaccine production at the Centre for Ticks and Tick Borne Diseases (CTTBD, Malawi) and development of an in vitro potency method |
CTTBD-GALVmed |
March 1, 2018 |
February 27, 2021 |
Viral reemerging enzootic and bee diseases |
East Coast fever, Theileria parva, ticks, in vitro cell cultures, immunohistochemistry |
|
Risk evaluation of irrigation of lettuce, carrots and strawberries with water contaminated with microcystine |
CYANTIR |
May 1, 2021 |
April 30, 2023 |
Organic contaminants and additives |
microcystin, food safety, LC-MS, cyanotoxins |
|
Development of methods for detection of infectious Hepatitis E (HEV) in pork meat products and optimisation of processing practices to reduce infectivity |
DECHAHEV |
January 1, 2019 |
January 1, 2023 |
Foodborne pathogens, Viral diseases |
hepatitis E, foodborne infection, pork meat, pig and wild boar food products, molecular methods, infectivity assays, meat processing |
|
Revision of the dermatophyte taxonomy |
DermatoTax |
January 1, 2016 |
December 31, 2019 |
Mycology and aerobiology |
dermatophytes, taxonomy, phylogeny, medical mycology, tinea |
|
The cost of current versus healthy sustainable diets in Belgium |
DIETCOST |
October 1, 2018 |
|
Health information |
cost of diets, food environments, affordability, sustainability, dietary guidelines, ultra-processed food products |
|
Development of a digital PCR method for accurate detection and quantification of SARS-CoV-2 |
DIGICOVID |
January 1, 2021 |
January 1, 2022 |
Viral diseases, Transversal activities in applied genomics, Viral reemerging enzootic and bee diseases |
ddPCR, epidemic, COVID-19, SARS-CoV-2, wastewater, clinical samples, surveillance |
|
Development of a digital PCR method for accurate detection and quantification of SARS-CoV-2 and its variants |
DIGICOVID_VAR |
January 1, 2021 |
January 1, 2022 |
Foodborne pathogens, Viral diseases, Transversal activities in applied genomics |
ddPCR, epidemic, COVID-19, SARS-CoV-2, wastewater, clinical samples, variants, surveillance |
|
Diagnosis, monitoring and prevention of exposure-related non-communicable diseases |
DiMoPEx |
April 11, 2016 |
April 10, 2020 |
Risk and health impact assessment |
environmental determinants, chronic diseases, network, Horizon 2020 programme |
|
DNA-debate |
DNA-debate |
February 1, 2018 |
November 1, 2020 |
Kankercentrum |
|
|
The Belgian Survey on Drugs |
DrugVibes |
April 1, 2019 |
|
Health information |
illegal drugs, illegal medicine, lifestyle risk factors, cannabis, weed, marijuana, hashish, powder cocaine, coke, crack cocaine, base, ecstasy, XTC, MDMA, amphetamines, speed, heroin, methamphetamines, crystal meth, GHB, GBL, liquid ecstasy, ketamine, LSD, hallucinogens, magic mushrooms, DMT, ayahuasca, alcohol, laughing gas, new psychoactive substances, opioid medication, tranquilizers, stimulant medication |
|
Characterization of e-cigarette emissions |
E-CIGAER |
November 16, 2022 |
November 15, 2024 |
Medicines and health products |
|
|
Characterisation and risk evaluation of electronic cigarettes and related products |
e-SMOKE |
November 3, 2015 |
November 2, 2019 |
Medicines and health products, Risk and health impact assessment |
e-cigarettes, quality control, nicotine replacement therapy, genotoxicity, mutagenicity |
|
European Antimicrobial Resistance Surveillance: Belgium |
EARS-BE |
January 1, 2000 |
|
Healthcare-associated infections and antimicrobial resistance |
klinisch laboratorium, ziekenhuis, zorginfectie, ECDC, WHO |
|
Mapping the Environmental Burden of Disease in Flanders |
EBoD-FL |
January 1, 2022 |
December 31, 2026 |
Risk and health impact assessment, Health information |
air pollution, comparative risk assessment, Environmental burden of disease, extreme temperatures, noise |
|
EU Joint Action on strengthening eHealth including telemedicine and remote monitoring for health care systems for cancer prevention and care |
eCAN JA |
September 15, 2022 |
September 15, 2024 |
Cancer centre |
networks, expertise, cancer |
|
Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals |
ECDC-PPS |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
nosocomial infection, healthcare-associated infection, antibiotics, acute hospitals |
|
Establishing of Cancer Mission Hubs: Networks and Synergies |
ECHos |
May 1, 2023 |
May 1, 2026 |
Cancer centre |
cancer, prevention, early detection & screening, rehabilitation, quality of life, paedeatric cancers, AI, Research |
